Trial intelligence / Profile preview

Cetirizine Dry Syrup in Children with Perennial Allergic Rhinitis

NCT00490204Phase 3Completed

Sponsor
GSK
Start
Jul 2007
Primary completion
Oct 2007
Modality
Small Molecules
Countries
1
01

Overview

A Phase 3 trial of cetirizine in perennial allergic rhinitis (PAR), sponsored by GSK. Started Jul 2007; status: completed.

02

Drugs

cetirizine
03

Conditions

perennial allergic rhinitis (PAR)

Beyond the preview

Go deeper on NCT00490204.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT00490204.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call